Second, the expanding indications for GLP-1 medications beyond weight loss are changing the eligibility landscape
There was no difference in these benefits between patients who lost 10% or more of their body weight, less than 10%, and those who gained weight while taking GLP-1s
Systematic reviews identify 36 studies demonstrating that BPC-157 improves functional, structural, and biomechanical outcomes across muscle, tendon, ligament, and bone injuries in preclinical models, with the peptide enhancing collagen synthesis, improving tensile strength, and accelerating cellular proliferation in tendon fibroblasts through FAK-paxillin pathway activation critical for cellular adhesion, migration, proliferation, and survival
Its unique lipid- and water-soluble composition enables effective action in various cellular environments, making it superior to vitamins C and E
It is important for providers to constantly screen and assess both motor and nonmotor symptoms to appropriately adjust therapies
